Catherine Schulte Analyst PerformanceSenior Research Analyst - Life Sciences & Diagnostics at Robert W. BairdCatherine Schulte is a stock analyst at Robert W. Baird focused in the medical sector, covering 13 publicly traded companies. Over the past year, Catherine Schulte has issued 28 stock ratings, including strong buy, buy, and hold recommendations. While full access to Catherine Schulte's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Catherine Schulte's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings41 Last 4 YearsBuy Recommendations76.92% 30 Buy RatingsCompanies Covered13 Unique Companies Ratings Distribution39RatingsDistribution of strong buy, buy, hold, and sell ratings by Catherine Schulte.RatingPercentageCount Strong Buy2.6%1 ratings Buy74.4%29 ratings Hold23.1%9 ratings Sell0.0%0 ratingsOut of 39 total stock ratings issued by Catherine Schulte at Robert W. Baird, the majority (74.4%) have been Buy recommendations, followed by 23.1% Hold and 2.6% Strong Buy.Best & Worst CallsBest Call00.0%TMOApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TECHNov 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ53.8% of companies on NASDAQ7 companiesNYSE46.2% of companies on NYSE6 companiesCatherine Schulte, an analyst at Robert W. Baird, currently covers 13 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical12 companies92.3%Services1 company7.7%Catherine Schulte of Robert W. Baird specializes in stock coverage within the Medical sector, with additional focus on Services companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE5 companies38.5%MED INSTRUMENTS2 companies15.4%MEDICAL SERVICES2 companies15.4%MED PRODUCTS2 companies15.4%SERVICES – HEALTH1 company7.7%MEDICAL INFO SYS1 company7.7% About Catherine SchulteCatherine Ramsey Schulte is Baird’s Senior Research Analyst covering Life Sciences & Diagnostics. Prior to joining Baird in 2014, she worked at Medtronic, Pathfinder Technologies and Vanderbilt University Medical Center. She also was an equity research intern at Avondale Partners, LLC. In the 2019 StarMine Analyst Awards by Refinitiv, Catherine was recognized as the No. 1 stock picker in Life Sciences Tools & Services. Catherine received a BSE in Biomedical Engineering from Duke University.Follow on LinkedIn Catherine Schulte's Ratings History at Robert W. Baird Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMTDMettler-Toledo International5/11/2026Lower Price Target$1,123.08$1,194.00Neutral$0.0000.00% ROIQGENQiagen4/29/2026Set Price Target$33.98$43.00Outperform$0.0000.00% ROIQGENQiagen4/29/2026Upgrade$33.61$43.00Strong-Buy$0.0000.00% ROITMOThermo Fisher Scientific4/24/2026Lower Price Target$466.93$639.00Outperform$0.0000.00% ROICAICaris Life Sciences2/27/2026Boost Price Target$19.24$28.00Outperform$0.0000.00% ROIGRALGRAIL2/17/2026Initiated Coverage$97.50$113.00Outperform$0.0000.00% ROITEMTempus AI2/17/2026Initiated Coverage$51.95$59.00Outperform$0.0000.00% ROIGHGuardant Health2/17/2026Initiated Coverage$104.85$120.00Outperform$0.0000.00% ROICAICaris Life Sciences2/17/2026Initiated Coverage$20.62$26.00Outperform$0.0000.00% ROICAICaris Life Sciences2/17/2026Initiated Coverage$20.80$26.00Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. GHGuardant Health2/17/2026Initiated Coverage$107.11$120.00Outperform$0.0000.00% ROIGRALGRAIL2/17/2026Initiated Coverage$99.03$113.00Outperform$0.0000.00% ROITEMTempus AI2/17/2026Initiated Coverage$52.56$59.00Outperform$0.0000.00% ROIAVTRAvantor2/12/2026Set Price Target$9.66$11.00$0.0000.00% ROIAAgilent Technologies11/25/2025Boost Price Target$153.24$165.00Outperform$0.0000.00% ROIEXASExact Sciences11/4/2025Boost Price Target$70.96$88.00Outperform$0.0000.00% ROIAVTRAvantor10/24/2025Boost Price Target$15.49$17.00Outperform$0.0000.00% ROIDHRDanaher10/22/2025Set Price Target$217.24$247.00$0.0000.00% ROIDHRDanaher10/15/2025Boost Price Target$211.96$236.00Outperform$0.0000.00% ROIAAgilent Technologies8/28/2025Boost Price Target$122.90$142.00Outperform$0.0000.00% ROIMTDMettler-Toledo International8/4/2025Boost Price Target$1,198.77$1,230.00Neutral$0.0000.00% ROIAVTRAvantor8/4/2025Lower Price Target$11.37$15.00Outperform$0.0000.00% ROIAVTRAvantor7/28/2025Boost Price Target$14.20$18.00Outperform$0.0000.00% ROIMTDMettler-Toledo International7/28/2025Boost Price Target$1,265.55$1,210.00Neutral$0.0000.00% ROITMOThermo Fisher Scientific7/24/2025Boost Price Target$466.84$567.00Outperform$0.0000.00% ROITMOThermo Fisher Scientific7/18/2025Lower Price Target$425.28$553.00Outperform$0.0000.00% ROIDHRDanaher7/18/2025Boost Price Target$194.81$226.00Outperform$0.0000.00% ROIAAgilent Technologies5/22/2025Lower Price Target$109.08$140.00Outperform$0.0000.00% ROIMRVIMaravai LifeSciences5/13/2025Lower Price Target$2.12$2.00Neutral$0.0000.00% ROIEXASExact Sciences5/2/2025Boost Price Target$47.16$72.00Outperform$0.0000.00% ROIAVTRAvantor4/28/2025Lower Price Target$12.93$17.00Outperform$0.0000.00% ROITMOThermo Fisher Scientific4/24/2025Lower Price Target$432.31$573.00Outperform$000.0000.00% ROIDHRDanaher4/23/2025Lower Price Target$192.06$225.00Outperform$000.0000.00% ROIMTDMettler-Toledo International4/22/2025Lower Price Target$971.31$1,034.00Neutral$0000.0000.00% ROIQGENQiagen4/21/2025Boost Price Target$42.84$45.26Neutral$00.0000.00% ROIAAgilent Technologies2/27/2025Lower Price Target$134.51$159.00Outperform$000.0000.00% ROIMRVIMaravai LifeSciences2/26/2025Downgrade$3.14$3.00Neutral$0.0000.00% ROITECHBio-Techne2/19/2025Downgrade$65.29$68.00Neutral$00.0000.00% ROIMTDMettler-Toledo International2/10/2025Boost Price Target$1,390.00$1,369.00Neutral$0000.0000.00% ROIDHRDanaher1/28/2025Lower Price Target$248.46$268.00Overweight$000.0000.00% ROIThe chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad)When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.See the stock Musk's own words pointed to right here Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
